Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288480227> ?p ?o ?g. }
- W4288480227 abstract "Abstract Background: One objective of the Belgian Rare Diseases plan is to improve patients’ management using phenotypic tests and, more specifically, the access to those tests by identifying the biochemical analyses used for rare diseases, developing new financing conditions and establishing reference laboratories. Methods: A feasibility study was performed from May 2015 until August 2016 in order to select the financeable biochemical analyses, and, among them, those that should be performed by reference laboratories. This selection was based on an inventory of analyses used for rare diseases and a survey addressed to the Belgian laboratories of clinical pathology (investigating the annual analytical costs, volumes, turnaround times and the tests unavailable in Belgium and outsourced abroad). A proposal of financeable analyses, financing modalities, reference laboratories’ scope and budget estimation was developed and submitted to the Belgian healthcare authorities. After its approval in December 2016, the implementation phase took place from January 2017 until December 2019. Results: In 2019, new reimbursement conditions have been published for 46 analyses and eighteen reference laboratories have been recognized. Collaborations have also been developed with 5 foreign laboratories in order to organize the outsourcing and financing of 9 analyses unavailable in Belgium. Conclusions: In the context of clinical pathology and rare diseases, this initiative enabled to identify unreimbursed analyses and to meet the most crucial financial needs. It also contributed to improve patients’ management by establishing Belgian reference laboratories and foreign referral laboratories for highly-specific analyses and a permanent surveillance, quality and financing framework for those tests." @default.
- W4288480227 created "2022-07-29" @default.
- W4288480227 creator A5008868137 @default.
- W4288480227 creator A5010491239 @default.
- W4288480227 creator A5014523202 @default.
- W4288480227 creator A5020594794 @default.
- W4288480227 creator A5023141160 @default.
- W4288480227 creator A5027914517 @default.
- W4288480227 creator A5030896841 @default.
- W4288480227 creator A5038750535 @default.
- W4288480227 creator A5043713972 @default.
- W4288480227 creator A5049870141 @default.
- W4288480227 creator A5052103341 @default.
- W4288480227 creator A5055841171 @default.
- W4288480227 creator A5059822463 @default.
- W4288480227 creator A5064590176 @default.
- W4288480227 creator A5069063123 @default.
- W4288480227 creator A5071488467 @default.
- W4288480227 creator A5071705224 @default.
- W4288480227 creator A5073816426 @default.
- W4288480227 creator A5074090438 @default.
- W4288480227 creator A5088802011 @default.
- W4288480227 date "2020-06-17" @default.
- W4288480227 modified "2023-09-26" @default.
- W4288480227 title "Belgian rare diseases plan in clinical pathology: identification of key biochemical diagnostic tests and establishment of reference laboratories and financing conditions" @default.
- W4288480227 doi "https://doi.org/10.21203/rs.3.rs-35562/v1" @default.
- W4288480227 hasPublicationYear "2020" @default.
- W4288480227 type Work @default.
- W4288480227 citedByCount "0" @default.
- W4288480227 crossrefType "posted-content" @default.
- W4288480227 hasAuthorship W4288480227A5008868137 @default.
- W4288480227 hasAuthorship W4288480227A5010491239 @default.
- W4288480227 hasAuthorship W4288480227A5014523202 @default.
- W4288480227 hasAuthorship W4288480227A5020594794 @default.
- W4288480227 hasAuthorship W4288480227A5023141160 @default.
- W4288480227 hasAuthorship W4288480227A5027914517 @default.
- W4288480227 hasAuthorship W4288480227A5030896841 @default.
- W4288480227 hasAuthorship W4288480227A5038750535 @default.
- W4288480227 hasAuthorship W4288480227A5043713972 @default.
- W4288480227 hasAuthorship W4288480227A5049870141 @default.
- W4288480227 hasAuthorship W4288480227A5052103341 @default.
- W4288480227 hasAuthorship W4288480227A5055841171 @default.
- W4288480227 hasAuthorship W4288480227A5059822463 @default.
- W4288480227 hasAuthorship W4288480227A5064590176 @default.
- W4288480227 hasAuthorship W4288480227A5069063123 @default.
- W4288480227 hasAuthorship W4288480227A5071488467 @default.
- W4288480227 hasAuthorship W4288480227A5071705224 @default.
- W4288480227 hasAuthorship W4288480227A5073816426 @default.
- W4288480227 hasAuthorship W4288480227A5074090438 @default.
- W4288480227 hasAuthorship W4288480227A5088802011 @default.
- W4288480227 hasBestOaLocation W42884802272 @default.
- W4288480227 hasConcept C10138342 @default.
- W4288480227 hasConcept C116834253 @default.
- W4288480227 hasConcept C144024400 @default.
- W4288480227 hasConcept C144133560 @default.
- W4288480227 hasConcept C160735492 @default.
- W4288480227 hasConcept C166957645 @default.
- W4288480227 hasConcept C17744445 @default.
- W4288480227 hasConcept C199360897 @default.
- W4288480227 hasConcept C199539241 @default.
- W4288480227 hasConcept C205649164 @default.
- W4288480227 hasConcept C2778012447 @default.
- W4288480227 hasConcept C2779343474 @default.
- W4288480227 hasConcept C2779703844 @default.
- W4288480227 hasConcept C2779903281 @default.
- W4288480227 hasConcept C36289849 @default.
- W4288480227 hasConcept C41008148 @default.
- W4288480227 hasConcept C59822182 @default.
- W4288480227 hasConcept C71924100 @default.
- W4288480227 hasConcept C86803240 @default.
- W4288480227 hasConceptScore W4288480227C10138342 @default.
- W4288480227 hasConceptScore W4288480227C116834253 @default.
- W4288480227 hasConceptScore W4288480227C144024400 @default.
- W4288480227 hasConceptScore W4288480227C144133560 @default.
- W4288480227 hasConceptScore W4288480227C160735492 @default.
- W4288480227 hasConceptScore W4288480227C166957645 @default.
- W4288480227 hasConceptScore W4288480227C17744445 @default.
- W4288480227 hasConceptScore W4288480227C199360897 @default.
- W4288480227 hasConceptScore W4288480227C199539241 @default.
- W4288480227 hasConceptScore W4288480227C205649164 @default.
- W4288480227 hasConceptScore W4288480227C2778012447 @default.
- W4288480227 hasConceptScore W4288480227C2779343474 @default.
- W4288480227 hasConceptScore W4288480227C2779703844 @default.
- W4288480227 hasConceptScore W4288480227C2779903281 @default.
- W4288480227 hasConceptScore W4288480227C36289849 @default.
- W4288480227 hasConceptScore W4288480227C41008148 @default.
- W4288480227 hasConceptScore W4288480227C59822182 @default.
- W4288480227 hasConceptScore W4288480227C71924100 @default.
- W4288480227 hasConceptScore W4288480227C86803240 @default.
- W4288480227 hasLocation W42884802271 @default.
- W4288480227 hasLocation W42884802272 @default.
- W4288480227 hasLocation W42884802273 @default.
- W4288480227 hasLocation W42884802274 @default.
- W4288480227 hasLocation W42884802275 @default.
- W4288480227 hasLocation W42884802276 @default.
- W4288480227 hasOpenAccess W4288480227 @default.
- W4288480227 hasPrimaryLocation W42884802271 @default.
- W4288480227 hasRelatedWork W1578603832 @default.
- W4288480227 hasRelatedWork W1995548574 @default.
- W4288480227 hasRelatedWork W2189228649 @default.